Revenue-growth signals Recent revenue boost from the MMT acquisition showing a 128% year-over-year lift in Q1; potential to upsell integration services, supply chain optimization, and specialty chemicals for new end-markets.

Acquisition-Driven expansion Historical acquisitions including Arysta LifeScience and MMT indicate a growth strategy via bolt-on capabilities; explore cross-sell of formulations, technical services, and global distribution partnerships to accelerate market reach.

Industrial-diversified demand Customer exposure across agriculture, electronics, metals, plastics, graphic arts, and offshore oil suggests multi-vertical chemical solutions; target industry-specific white papers and bundles that address sector-specific dynamics.

Tech-enabled selling Tech stack signals capability in digital engagement and analytics; leverage data-driven targeting, enablement tools, and digital product demonstrations to shorten sales cycles and highlight dynamic chemistries.

Leadership and governance Past leadership transitions and CFO appointment indicate a focus on financial discipline and performance; present ROI-focused propositions, risk-adjusted pricing, and value-based contracts aligned with corporate governance interests.